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Virus–host interactions play vital roles in viral replication and virus-induced pathogenesis.
Viruses rely entirely upon host cells to reproduce progeny viruses; however, host factors
positively or negatively regulate virus replication by interacting with viral proteins. The
elucidation of virus–host protein interaction not only provides a better understanding of
the molecular mechanisms by which host cells combat viral infections, but also facilitates
the development of new anti-viral therapeutics. Identification of relevant host factors
requires techniques that enable comprehensive characterization of virus–host protein
interactions. In this study, we developed a proteomic approach to systematically identify
human protein kinases that interact potently with viral proteins. For this purpose, we
synthesized 412 full-length human protein kinases using the wheat germ cell-free protein
synthesis system, and screened them for their association with a virus protein using the
amplified luminescent proximity homogenous assay (AlphaScreen). Using this system,
we attempted to discover a robust anti-viral host restriction mechanism targeting virus
protein X (Vpx) of HIV-2. The screen identified H11/HSPB8 as a Vpx-binding protein
that negatively regulates the stability and function of Vpx. Indeed, overexpression of
H11/HSPB8 promoted the degradation of Vpx via the ubiquitin–proteasome pathway
and inhibited its interaction with SAMHD1, a host restriction factor responsible for
blocking replication of HIV. Conversely, targeted knockdown of H11/HSPB8 in human
trophoblast cells, which ordinarily express high levels of this protein, restored the
expression and function of Vpx, making the cells highly susceptible to viral replication.
These results demonstrate that our proteomic approach represents a powerful tool for
revealing virus–host interaction not yet identified by conventional methods. Furthermore,
we showed that H11/HSPB8 could be a potential host regulatory factor that may prevent
placental infection of HIV-2 during pregnancy.
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INTRODUCTION
To replicate and propagate, viruses utilize sophisticated
mechanisms to hijack the machinery and materials of their host
cells. In a virally infected cell, host proteins play crucial roles
in multiple biological processes that promote viral replication
by providing molecular architecture or functional assistance.
To this end, viral proteins need to interact directly or indirectly
with host cell proteins that are relevant to the viral life cycle.
On the other hand, some host proteins operate as anti-viral
factors to counteract or restrict viral replication within infected
cells. In turn, certain viral proteins counteract these anti-viral
proteins, resulting in sustained viral propagation. Therefore, a
comprehensive understanding of dynamic host–virus protein
interaction would greatly improve our understanding of the viral
life cycle and pathogenesis.
Recent technological advances in high-throughput and
quantitative proteomics have enabled us to comprehensively
analyze biologically relevant protein–protein interactions. In
particular, the development of cell-free protein synthesis
(CFPS) systems has enabled high-yield production of active
and functional proteins that can be used for biological
analysis (Sawasaki et al., 2002; Endo and Sawasaki, 2006;
Zawada et al., 2011). Moreover, advances in label-free protein
detection techniques enable reliable, high-throughput analysis
of protein–protein interactions (Sawasaki et al., 2007). Protein–
protein interactions can be also predicted by approaches that
combine bioinformatics and structural biology (Roy et al.,
2010; Roche et al., 2015). Together, these techniques have
contributed to the establishment of comprehensive protein
interaction networks, which facilitate understanding of biological
mechanisms, both in cells and in the context of viral
infection.
Recombinant protein production and purification are
essential steps for biochemical and functional characterization
of virus and host proteins. In general, however, viral protein
expression is limited due to the toxicity and insolubility of
viral proteins in living cells (Harbers, 2014; Gagoski et al.,
2016). Compared with conventional cell-mediated protein
expression methods, the wheat germ CFPS system is more
likely to produce properly folded, soluble, and functional virus-
encoded proteins. Previous reports showed that the wheat germ
system has several advantages over protein expression in other
CFPS system such as E. coli or HeLa cells, including improved
protein solubility and expression of toxic proteins such as viral
antigens (Gagoski et al., 2016). Thus, the wheat germ CFPS
system represents a rapid and high-throughput methodology
for translation of genetic information into protein-mediated
biochemical activities for use in virological research (Sawasaki
et al., 2007).
Methods for detecting protein–protein interactions can be
categorized into several types: most broadly, in vitro, in vivo,
and in silico methods. Among in vitro methods, the AlphaScreen
(derived from “Amplified Luminescent Proximity Homogeneous
Assay”) technology offers a rapid and simple means for
quantifying target protein–protein interactions using a non-
radioactive bead-based detection method. Upon excitation at
680 nm, the donor beads, which contain the photosensitizer
phthalocyanin, convert molecular oxygen to excited singlet
oxygen with a 4 µs half-life. The singlet oxygen can diffuse
up to 200 nm to make contact with a thioxene derivative
on the AlphaScreen acceptor beads, resulting in amplified
chemiluminescent emission between 520 and 620 nm. One
donor bead can generate 60,000 singlet oxygens, resulting in
exceptionally high signal amplification and permitting adaptation
of the AlphaScreen assay to multi-well plate formats (Taouji
et al., 2009). Thus, the AlphaScreen technology is suitable for
high-throughput analysis of protein–protein interactions.
Viral proteins are controlled by post-translational
modifications such as phosphorylation during infection (Nandi
and Banerjee, 1995; Rajendra Kumar et al., 2005; Hemonnot
et al., 2006; Kudoh et al., 2014). Phosphorylation acts as a
molecular switch of target protein, thereby modulating their
functions. We previously showed that HIV-1 Gag was regulated
by the aPKC-mediated phosphorylation by using a human
protein kinase library (Kudoh et al., 2014). Identification of
human protein kinases that interact with viral protein could be
effective approach to reveal a novel viral–host interaction. HIV-2
encodes an accessory protein Vpx that degrades SAMHD1, a host
restriction factor. Although previous reports suggested that HIV-
2 Vpx is phosphorylated during infection (Nandi and Banerjee,
1995; Rajendra Kumar et al., 2005), it still remains uncertain if
Vpx phosphorylation indeed affects to functions of Vpx toward
SAMHD1 degradation. Thus, we decided to investigate molecular
interaction between human protein kinases with HIV-2 Vpx
protein.
In this study, we performed a high-throughput screen of
interactions between viral and host proteins using the wheat germ
CFPS system and AlphaScreen. As an illustrative example, we
analyzed the functional interaction between HIV-2 Vpx and host
protein kinases in order to elucidate the function of Vpx protein.
Furthermore, we describe the results of a pilot study designed
to test the experimental feasibility of our in vitro assay system,
and discuss the optimal strategy for characterizing virus–host
interactions.
MATERIALS AND METHODS
Viral DNA Constructs and Plasmids
HIV-2 reporter virus vectors pGL-AN1Env-Luc and pGL-
St1Env1Vpx-Luc were kindly provided by Dr. Akio Adachi
(Tokushima University, Tokushima, Japan). Plasmids expressing
FLAG-tagged Vpx were kindly provided by Dr. Akio Adachi
(Tokushima University, Tokushima, Japan; Khamsri et al., 2006).
Vpx deletion mutants and H11 substitution mutants were
generated by PCR-based molecular cloning procedures using
PrimeSTAR Max (Takara Bio Inc, Shiga, Japan).
Antibodies
Anti-FLAG (M2), anti-SAMHD1, and anti-vinculin mouse
monoclonal antibodies were obtained from Sigma (St. Louis, MO,
USA). Anti-HA (3F10) rat monoclonal antibody was obtained
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from Roche (Mannheim, Germany). Anti-Hsp22 (H11) rabbit
polyclonal antibody was from Abcam (Tokyo, Japan).
Cells and Viruses
HEK293 and HEK293T cells were cultured in DMEM (Gibco-
BRL, Rockville, MD, USA) supplemented with 10% (V/V) fetal
bovine serum (FBS; Gibco-BRL). Human villous trophoblasts
(HVT; ScienCell Research Laboratories, USA, HVT were isolated
from human placental villi and cryopreserved at passage primary
culture). Pavlov et al. (2003) were cultured in Trophoblast
Medium (ScienCell Research Laboratories, Carlsbad, CA, USA).
THP-1 cells were cultured in RPMI containing 10% FBS.
THP-1 cells were differentiated overnight with 50 ng/ml
of phorbol 12-myristate 13-acetate (PMA; Sigma–Aldrich).
Vesicular stomatitis virus G glycoprotein (VSV-G)-pseudotyped
viruses were produced in HEK293T cells co-transfected with
reporter virus and VSV-G plasmids using the calcium-phosphate
method. Culture supernatants were collected, and HIV-2 particle
yields were quantitated by p27 antigen capture enzyme-
linked immunosorbent assay (ELISA; ZeptoMetrix, Buffalo,
NY, USA).
In vitro Protein Production
A total of 412 cDNAs encoding human protein kinases were
generated as described previously (Tadokoro et al., 2010).
The protein production method was also described previously
(Sawasaki et al., 2002, 2007; Takai et al., 2010). Briefly, DNA
templates containing a biotin-ligating sequence (bls) were
amplified by split-PCR using cDNAs and corresponding primers,
and then used in a GenDecoder protein production system (Cell
Free Science, Ehime, Japan). For synthesis of HIV-2 Vpx protein,
Vpx genes derived from the pGL-AN proviral plasmid were
generated by split-PCR and used as templates in the Wheat Germ
Expression kit (Cell Free Science).
AlphaScreen-Based Protein–Protein
Interaction Assays
AlphaScreen assays were performed as described previously
(Tadokoro et al., 2010). All recombinant proteins were
synthesized using the wheat germ CFPS system, as described
above. For each protein kinase, 1 µl of crude recombinant
biotinylated construct from the human kinase library was
incubated with 1 µl of crude FLAG-Vpx or FLAG-DHFR in
10 µl of kinase assay buffer (100 mM Tris-HCl [pH 8.0], 10 mM
MgCl2, 0.1% Tween-20, 0.1% BSA) at 37◦C for 1 h in one
well of a 384-well OptiPlate (PerkinElmer, Foster City, CA,
USA). Using the AlphaScreen IgG (protein A) detection kit
(PerkinElmer), 15 µl of detection mixture containing 100 mM
Tris-HCl [pH 8.0], 0.01% Tween-20, 1 mg/ml BSA, 5 µg/ml anti-
FLAG antibody (GE Healthcare, Buckinghamshire, UK), 5 ng
streptavidin-coated donor beads, and 5 ng anti-IgG (protein A)
acceptor beads were added to each well, followed by incubation at
26◦C for 1 h. AlphaScreen signals were detected on an EnVision
device (PerkinElmer) using the AlphaScreen signal detection
program.
In vitro Kinase Assays
Biotinylated-DHFR, H11, SAMHD1, and FLAG-Vpx proteins
were synthesized in the wheat germ CFPS system, as described
above. The synthesized proteins were purified using streptavidin-
conjugated magnet beads (Promega, Madison, WI, USA) or
Flag M2 beads (Sigma–Aldrich). Purified FLAG-Vpx proteins
were then incubated with each biotinylated protein in a 50 µl
reaction mixture containing 20 mM Tris-HCl (pH 7.5), 1 mM
EDTA, 1 mM dithiothreitol, 150 mM NaCl, 5 mM MgCl2,
0.05% Tween-20, 100 µM ATP, and 2 µCi [γ-32P]ATP. The
reaction mixture was incubated for 1 h at 37◦C, and the products
were subjected to electrophoresis on 10% SDS polyacrylamide
gels and detected on a BAS2500 scanner (Fujifilm, Tokyo,
Japan).
Western Blotting
Cells were harvested at the indicated time points, washed with
phosphate-buffer saline (PBS), and treated with lysis buffer
(0.02% sodium dodecyl sulfate [SDS], 0.5% Triton X-100,
300 mM NaCl, 20 mM Tris-HCl [pH 7.6], 1 mM EDTA, 1 mM
dithiothreitol) for 20 min on ice. Multiple protease inhibitors,
200 µM sodium vanadate, and 20 mM sodium fluoride were
then added to the buffer. The samples were centrifuged at
18,000 g for 10 min at 4◦C, and the clarified cell extracts were
assayed for protein concentration using DCTM protein assay
kit (Bio-Rad, Hercules, CA, USA). Equal amounts of proteins
(20–50 µg) were resolved by SDS-PAGE on 10% gels (acrylamide,
29.2; bisacrylamide, 0.8) in running buffer (250 mM glycine,
25 mM Tris, 0.1% SDS). The separated proteins were transferred
to polyvinylidene difluoride membrane. The membranes were
washed with blotting buffer (TBS containing 0.1%-Tween 20),
and then blocked for 1 h at room temperature in 10% non-
fat powdered milk in blotting buffer. Primary antibodies were
added at appropriate dilutions in 3% bovine serum albumin in
blotting buffer and rocked overnight at 4◦C. The membranes
were then washed in blotting buffer and incubated for 1 h
at room temperature with a horseradish peroxidase–conjugated
secondary antibody. Target proteins were detected using an
enhanced chemiluminescence detection system (GE Healthcare).
Images were processed with FluorChem FC2 (Alpha Innotech
Corp. Tokyo, Japan), acquired using a cooled charge-coupled
device (CCD) camera, and assembled using Adobe Photoshop
CS5 Extended.
Immunoprecipitation
HEK293 cells were co-transfected with HA-H11 and FLAG-
Vpx, and treated with 20 µM of MG132 for 4 h before
harvest. Harvested cells were lysed in lysis buffer (50 mM
Tris-HCl [pH 8.0], 150 mM NaCl, 1 mM EDTA, 1 mM
DTT) containing complete protease inhibitor cocktail (Roche
Molecular Biochemicals, Indianapolis, IN, USA) and PhosSTOP
phosphatase inhibitor cocktail (Roche Molecular Biochemicals).
Lysates were cleared by centrifugation at 12,000 × g for 15 min,
followed by pull-down with anti-FLAG M2 affinity Gel (Sigma)
or anti-HA affinity Gel (Sigma). Samples were separated by SDS-
PAGE and analyzed by Western blotting.
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Phosphatase Treatment
HEK293 cells were co-transfected with plasmids encoding HA-
H11 and harvested at 24 h after transfection. Harvested cells
were suspended with lysis buffer (0.02% sodium dodecyl sulfate
[SDS], 0.5% Triton X-100, 300 mM NaCl, 20 mM Tris-HCl
[pH 7.6], 1 mM EDTA, 1 mM dithiothreitol and Complete
[Roche, Basel, Switzerland]) for 20 min on ice. The lysate was
then incubated in reaction buffer and calf intestinal alkaline
phosphatase (CIAP; Takara Bio Inc., Shiga, Japan) for 2 h at
37◦C. The reaction was stopped by the addition of 2 x sample
buffer.
Single-Cycle Virus Release Assays
For HA-H11 overexpression assays, PMA differentiated THP-1
cells were transfected with HA-H11 plasmids with Lipofectamin
3000 (Thermo Fisher Scientific, Waltham, MA USA), and
24 h after transfection cells were infected with VSV-G-
pseudotyped HIV-2 at a multiplicity of infection (MOI) of 2,
and cultured for 2 days. For small interfering RNA (siRNA)
targeting H11 transfected assays, HVT cells were transfected with
H11 specific siRNA, GGAGUUGAUGGUGAAGACCAAAGAU,
purchased from invivogen (invivogen, San Diego, CA, USA)
with using RNAiMAX (Thermo Fisher Scientific, Waltham,
MA, USA), and 24 h after transfection cells were infected
with VSV-G-pseudotyped HIV-2 at a MOI of 2, and cultured
for 2 days. Cell lysates were prepared using HBST buffer
(10 mM HEPES [pH 7.4] 150 mM NaCl, 0.5% Triton X-
100) containing protease inhibitor cocktail (Roche, Basel,
Switzerland).
Tissue Collection
A fallopian tube resected from a patient with ectopic tubal
pregnancy was retrieved from the archives of Seirei Hamamatsu
General Hospital, Shizuoka, Japan.
Immunohistochemistry
Unstained sections were deparaffinized and rehydrated prior to
antigen retrieval. Antigen retrieval was performed in 10 mmol/L
citrate buffer (pH 6.0) in a microwave oven. Sections were
incubated with anti-Hsp22 antibody for 30 min at room
temperature. After washing in PBS, the sections were incubated
with peroxidase-conjugated universal immune-enzyme polymer,
anti-rabbit solution (Histofine Simple Stain MAX PO-R Nichirei
Biosciences, Tokyo, Japan), and then visualized with 3,3-
diaminobenzidine (Sigma–Aldrich) and counterstained with
hematoxylin.
Ethical Statement
Ethical approval was obtained from the Ethical Committee of
Seirei Hamamatsu General Hospital, Shizuoka, Japan (September
22, 2010, #917). A patient provided written informed consent for
the collection of samples and subsequent analysis.
Statistical Analysis
Statistical analysis was performed using the Excel Tokei software
series (Esumi, Tokyo, Japan). Data are presented as means± SD.
One-way analysis of variance (ANOVA) and Student’s t-test were
used for comparisons of continuous variables. P < 0.05 was
considered significantly different.
RESULTS
Design and Development of a
High-Throughput Protein–Protein
Interaction Screen
To build a system for high-throughput protein–protein
interaction screening, we utilized a wheat germ CFPS system
to synthesize a set of proteins from a host cDNA library
(Figure 1A). Linear DNAs used as translation templates for
CFPS were PCR amplified from a plasmid library of human
protein kinase cDNAs. In this step, the template DNAs were
fused at the 5′ end to a specific sequence from the SP6 promoter,
the E02 enhancer region, and a bls by split-primer PCR using
appropriate primers (Sawasaki et al., 2008; Matsuoka et al.,
2010). The templates were then transcribed by SP6 RNA
polymerase, and the resultant mRNAs were translated in wheat
germ extracts. The biotin ligation method yields a biotin label
on the bls, allowing specific recognition of the target protein
by Amplified Luminescent Proximity Homogenous Assay
(AlphaScreen).
Identification of Host Protein Kinases
that Interact with HIV-2 Vpx
Protein kinases are enzymes that modify substrate proteins
by chemical addition of phosphate groups. Phosphorylation
usually results in structural and functional changes in the
target protein. Therefore, we investigated functional modification
of virus protein by host protein kinases. As an illustration,
we sought to identify host protein kinases that functionally
associate with the HIV-2 accessary protein Vpx. To this
end, we quantitatively monitored protein–protein interactions
using AlphaScreen (Figure 1B). The binding efficiency of
HIV-2 Vpx with each kinase was normalized relative to the
luminescent activity of DHFR protein, used as a negative
control (Figure 1C). When a relative light unit per cutoff
(RLU/Co) ratio of ≥2.25 was used as the threshold, we found
15 host kinases that could selectively interact with HIV-2
Vpx. Among them, the luminescence signal of H11 (also
known as HSPB8) was significantly higher than that of other
kinases. Our assay detected Fyn and Erk2 as Vpx interactor
(S/N = 2.85 and 1.36, respectively), both of which have been
already reported to phosphorylate Vpx (Rajendra Kumar et al.,
2005; Singhal et al., 2006). Therefore, we focused on functional
analysis of H11 as a previously uncharacterized Vpx-interacting
factor.
To confirm the Vpx–H11 interaction, we performed pull-
down assays. For this purpose, biotin-labeled H11, DHFR
(negative control), SAMHD1 (positive control), and FLAG-
tagged Vpx proteins were synthesized individually by wheat
germ CFPS. Each biotin-labeled protein was mixed with
FLAG-Vpx, and then immunoprecipitated with sepharose
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FIGURE 1 | AlphaScreen-based screening of virus–host proteins interactions. (A) Schematic representation of the overall screening procedure.
(B) Schematic representation of the AlphaScreen-based luminescent system used to screen for human protein kinases that interact with HIV-2 Vpx. All recombinant
proteins were produced in the wheat germ CFPS system. Briefly, recombinant FLAG-tagged HIV-2 Vpx or dihydrofolate reductase (DHFR) was incubated with each
protein kinase. Protein A–conjugated acceptor beads with anti-FLAG antibody and streptavidin-coated donor beads were added and bound to the tagged
substrate. Upon laser excitation, the donor beads convert ambient oxygen to singlet oxygen. When a molecular interaction occurs between HIV-2 Vpx and a
particular kinase, singlet oxygen transfers to the acceptor beads, activating emission of light at 520–620 nm. (C) HIV-2 Vpx–interacting kinases identified from a
human protein kinase library by AlphaScreen. The binding efficiency of HIV-2 Vpx with each kinase was normalized relative to the luminescence of control DHFR.
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FIGURE 2 | H11 interacts with HIV-2 Vpx. (A) Direct interaction between H11 and HIV-2 Vpx revealed by FLAG pull-down assays. Biotinylated H11,
SAMHD1, DHFR, and FLAG-tagged HIV-2 Vpx were produced in the wheat germ CFPS system and affinity-purified. Both input and pull-down samples
were subjected to western blotting with HRP-streptavidin and anti-FLAG antibody. (B) Immunoprecipitation of HIV-2 Vpx with H11. HEK293T cells were
co-transfected with HA-tagged H11, H11K141E, or H11K113G and FLAG-tagged HIV-2 Vpx in the presence of MG132, and cell lysates were
immunoprecipitated with anti-FLAG or anti-HA antibody 24 h later. Input and immunoprecipitation samples were then probed with anti-HA and anti-FLAG
antibodies. (C) Confocal microscopy analysis of HA-tagged H11 and FLAG-tagged HIV-2 Vpx in HEK293T cells. Scale bar, 10 µm. (D) In vitro
phosphorylation assay of H11. FLAG-tagged DHFR, Vpx, and GST-tagged H11 were produced in the wheat germ CFPS system and affinity-purified.
H11-mediated phosphorylation was assessed by incubating recombinant FLAG-DHFR or FLAG-Vpx with recombinant active GST-H11 in the presence of
[γ-32P] ATP. The reaction products were analyzed by autoradiography. Left panel shows a western blot of the input recombinant proteins. (E) H11
proteins mobility shifts in Phos-tag Gel. HEK293 cells were transfected with plasmids encoding HA-H11 or HA-H11K113G (100 ng). Right panel shows
separation of HA-H11 with or without CIAP, phosphatase, treatment by Phos-tag affinity approach. The transfected cells were harvested at 24 h
post-transfection, and then treated with CIAP. Equal amounts of cell lysates were subjected to a 50 µM phos-tag containing gel or a normal SDS-PAGE
and then analyzed by Western blot analysis with HA or Vinculin antibodies. The arrow indicate the position of wild type H11. Phospho-H11 indicates
phosphorylated form of H11.
beads conjugated to anti-FLAG antibody (FLAG-beads). H11
was co-precipitated with FLAG-Vpx protein (Figure 2A).
As reported previously (Hrecka et al., 2011; Laguette et al.,
2011), SAMHD1 protein associated with FLAG-Vpx protein
(Figure 2A). To further validate the interaction, we performed
cell-based immunoprecipitation analysis using site-directed
H11 mutants, a chaperon-like activity–deficient mutant K141E
(Irobi et al., 2004; Shemetov et al., 2008; Shemetov and Gusev,
2011) and a kinase-activity–deficient mutant K113G (Smith
et al., 2000). FLAG-Vpx was co-transfected with either HA-
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tagged wild type H11 or mutants in HEK293T, and cell
lysates were immunoprecipitated using anti-FLAG or anti-HA
affinity beads. The wild type and mutant forms of H11 were
co-immunoprecipitated with Vpx, and Vpx protein was also
co-precipitated with all three forms of H11 (Figure 2B),
indicating that H11 interacts with HIV-2 Vpx in vitro and in cells,
irrespective of its kinase or chaperon activity. Moreover, we found
that HA- H11 was co-localized with FLAG-Vpx protein in the
cytoplasm (Figure 2C).
We next investigated whether H11 could directly
phosphorylate Vpx protein in vitro. Recombinant FLAG-
DHFR or FLAG-Vpx proteins were synthesized and purified
from wheat germ extract with FLAG beads and used as
substrates for in vitro kinase assays. H11 did not phosphorylate
Vpx, as was also the case for the negative control DHFR,
although prominent auto-phosphorylation of H11 was observed
(Figure 2D). We next analyzed the kinase activity of wild
type and H11K113G, kinase activity deficient mutant, using
Phos-tag affinity approach and western blot (Kinoshita et al.,
2006). The phosphorylation of wild type H11 was detected
as a distinct band shift. This was not a case with H11K113G
mutants. The pre-treatment of cell lysates with calf intestine
alkaline phosphatase (CIAP) resulted in the loss of band shift,
indicating that shifted band represented phosphorylated H11
(Figure 2E).
Next, we attempted to identify the binding domain of Vpx
with H11. To this end, we used the full-length form of Vpx
(residues 1–112) and three deletion mutants (Vpx 1–90, 23–90,
and 40–112) (Figure 3A). As shown in Figure 3A, full-length
Vpx, C-terminally deleted Vpx (Vpx 1–90), and N-terminally
deleted Vpx (Vpx 40–112) could precipitate with HA-H11
protein, but Vpx lacking both the N-terminal and C-terminal
regions (Vpx 23–90) could not. These results demonstrated that
either the N-terminus or C-terminus of Vpx is sufficient for the
physical association with H11.
To better understand the functional relevance of the Vpx–
H11 interaction, we investigated whether H11 could affect Vpx
protein expression. Overexpression of HA-H11 repressed the
expression of full-length Vpx but not the truncated mutant Vpx
23–90 (Figure 3B). Vpx can degrade SAMHD1 in a proteasome-
dependent manner (Hrecka et al., 2011; Laguette et al., 2011).
Consistent with this, the level of endogenous SAMHD1 decreased
upon expression of wild-type (WT) FLAG-Vpx. The reduction
in Vpx level resulting from HA-H11 overexpression restored
endogenous SAMHD1 expression.
Previous reports showed that N-terminal regions of Vpx
includes responsible domain for the interaction with SAMHD1
(Schwefel et al., 2014), and our results above indicate that
H11 binds both the N- and C- termini of Vpx. Based on the
crystal structure of the Vpx–SAMHD1 complex (Schwefel et al.,
2014), the N-terminal SAMHD1-binding region within Vpx may
overlap with the H11-binding region (Figure 3C), so that H11
may interfere with the SAMHD1-Vpx interaction. To test this
hypothesis, we performed in vitro binding assays for the Vpx-
SAMHD1 interaction in the presence of various amounts of H11.
The results revealed that H11 inhibited the interaction between
SAMHD1 and Vpx (Figure 3D). Collectively, our results suggest
that H11 can not only enhance degradation of Vpx, but also
directly inhibit its interaction with SAMHD1 for proteasomal
degradation.
H11 Degrades Vpx in a
Proteasome-Dependent Manner
Next, we asked whether H11 affects the stability of Vpx in cells.
Transient transfection of FLAG-Vpx significantly decreased the
level of endogenous SAMHD1 in HEK293 cells, as previously
reported (Figure 4A, lanes 1 and 2) (Hrecka et al., 2011).
Moreover, levels of FLAG-Vpx protein were reduced by co-
transfection of HA-H11 protein in a dose dependent manner,
resulting in restoration of SAMHD1 expression (Figure 4A).
Overexpression of HA-H11 itself was no effect on endogenous
SAMHD1 expression (Figure 4B). Degradation of Vpx protein
by H11 was completely prevented by the proteasome inhibitor
MG132 (Figure 4C). Next, we co-transfected HEK293 cells with
FLAG-Vpx and WT H11, the kinase activity–deficient mutant
K113G (Smith et al., 2000), or the chaperon-like activity–deficient
mutant K141E (Shemetov and Gusev, 2011). Relative to vector
control, WT H11 and the K113G mutant prominently reduced
the level of Vpx, whereas the K141E mutant did not (Figure 4D).
We then performed a cycloheximide (CHX) assay to determine
the effect of H11 on the half-life of Vpx. In these experiments,
HEK293 cells were co-transfected with FLAG-Vpx and HA-
H11 WT or mutants, and then treated with CHX to inhibit
translation. As shown in Figure 4E, the stability of FLAG-Vpx
was significantly reduced by WT H11 and the K113G mutant,
whereas expression of the K141E mutant had no effect. These
results demonstrated that H11 promotes proteasome-dependent
degradation of Vpx via its chaperone-like activity.
H11 Suppresses HIV-2 Infection in
Monocyte-Derived Macrophages
Vpx degrades SAMHD1 in order to evade host intrinsic
intracellular immunity and allow sustained HIV replication
in myeloid cells (Goldstone et al., 2011; Hrecka et al., 2011;
Laguette et al., 2011; Baldauf et al., 2012; Descours et al., 2012;
Lahouassa et al., 2012). Therefore, we investigated whether
H11-mediated Vpx degradation affects HIV-2 replication in
monocyte-derived macrophages (MDMs). For this purpose, we
used an HIV-2 clone harboring the luciferase gene (HIV-2-
1env-LUC) and its vpx-deficient mutant (HIV-21env1vpx-
LUC) to produce chimeric viruses with the fusogenic envelope
G glycoprotein of the VSV-G (Figure 5A). The infectivity
of the generated viruses was tested using MDMs transfected
with HA-H11 or vector alone. H11 overexpression suppressed
infection of MDMs by WT HIV-2, but not Vpx-deficient
HIV-2 (Figure 5B). SAMHD1 expression was significantly
reduced in cells infected by WT HIV-2 (Figure 5C, lane 3),
as reported in previous studies (Hrecka et al., 2011; Laguette
et al., 2011). On the other hand, the level of SAMHD1
was restored in H11-transfected cells (Figure 5C, lane 4).
These results suggested that H11 suppresses HIV-2 infection
in MDMs via the up-regulation of SAMHD1-mediated virus
restriction.
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FIGURE 3 | Domains in HIV-2 Vpx that mediate physical interactions with H11. (A) Top panel shows a schematic representation of the wild-type (WT; residues
1–112) and mutant Vpx proteins utilized in the FLAG-pull-down analysis. The name of each Vpx mutant is shown on the left. WT Vpx or the indicated mutants were
co-transfected with HA-tagged H11 into HEK293T cells. The transfected cells were treated with 20 µM of MG132 for 4 h before harvest, and harvested at 48 h after
transfection. Cell lysates were immunoprecipitated with anti-FLAG antibody. The immunoprecipitated proteins, as well as the starting material (INPUT), were
subjected to SDS-PAGE and analyzed by western blot using anti-FLAG and anti-HA antibodies. (B) HEK293 cells were transfected with WT (top panel) or truncated
mutant (bottom panel) FLAG-Vpx and HA-H11, as indicated. Whole cell extracts were prepared, and equal amounts of proteins from each sample were separated
by SDS-PAGE and subjected to western blot analysis using the indicated antibodies. (C) Binding structure model of SAMHD1 C-terminal domain (magenta) and Vpx
(gray) illustrated by Chimera (http://www.cgl.ucsf.edu/chimera/), based on the X-ray structure (PDB code: 4CC9). The H11-binding domain (blue) was overlaid on
Vpx. Bottom panel shows schematic image of Vpx protein. The SAMHD1-binding region is indicated in magenta, and the H11-binding region is indicated in blue.
(D) Recombinant biotinylated Vpx was pre-mixed with various amounts of H11 for 10 min before the addition of FLAG-tagged SAMHD1. After 60 min, the mixture
was processed for pull-down with streptavidin-coated magnetic beads, as shown on the right. Bound proteins were detected by western blot (left panel).
H11 is Highly Expressed in
Syncytiotrophoblast Cells
According to the Human Protein Atlas database, H11 mRNA is
significantly highly expressed in placenta (Figure 6A)1 (Uhlen
et al., 2005, 2010, 2015; Berglund et al., 2008; Ponten et al.,
2008). We analyzed H11 protein levels of in various cell
1www.proteinatlas.org
lines. There was no obvious expression of H11 in the human
monocyte/macrophage cell lines THP-1 and MonoMac6. By
contrast, H11 was highly expressed in HVTs, a cell line derived
from primary trophoblasts (Figure 6B). To test whether H11
can interact with Vpx in trophoblast cells, we performed an
immunoprecipitation analysis using FLAG-Vpx transfected HVT
cell extract. Endogenous H11 protein was co-precipitated with
FLAG-Vpx (Figure 6C). These data prompted us to assess H11
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FIGURE 4 | Aberrant expressed H11 degrades HIV-2 Vpx in mammalian cells. (A) HA-H11 degrades FLAG-Vpx. HEK293 cells were co-transfected with
plasmids encoding FLAG-Vpx (50 ng) and HA-H11 (100 or 300 ng). Equal amounts of proteins for each sample were separated by SDS-PAGE and subjected
western blot analysis using the indicated antibodies. The relative SAMHD1 expression level are shown as indicated. (B) HA-H11 expression does not effect on
SAMHD1 expression. HEK293 cells were transfected with plasmid encoding HA-H11 (100 or 200 ng). Equal amounts of proteins for each sample were separated by
SDS-PAGE and subjected western blot analysis using the indicated antibodies. The relative SAMHD1 expression levels are shown as indicated. (C) H11-dependent
Vpx degradation is inhibited by MG132 treatment. HEK293 cells were co-transfected with plasmids encoding FLAG-Vpx (50 ng) and HA-H11 (200 ng), and then
treated with or without 20 µM of MG132 treatment for 4 h. Equal amounts of proteins for each sample were separated by SDS-PAGE and subjected to western blot
analysis using the indicated antibodies. (D) H11 degrades Vpx via its chaperone activity. HEK293 cells were co-transfected with plasmids encoding FLAG-Vpx and
the indicated HA-H11 variants (WT, K113G, or K141E). Cell lysates were subjected to western blotting using the indicated antibodies. (E) FLAG-Vpx cycloheximide
chase analysis in cells expressing HA-H11. HEK293 cells were co-transfected with plasmids encoding FLAG-Vpx and the indicated HA-H11 variant (WT, K113G, or
K141E), and then treated with or without cycloheximide. Equal amounts of proteins for each sample were separated by SDS-PAGE and subjected to western blot
analysis using theanti-FLAG or anti-Vinculin antibodies. Left panel shows quantitation of signal intensity.
expression in human placenta tissues. Immunohistochemistry
(IHC) revealed that H11 was specifically expressed both in
syncytiotrophoblast and cytotrophoblast cells, this was more
prominently in syncytiotrophoblast, which form the border
surface of placenta with the maternal circulation (Figure 6D).
Targeted Depletion of H11 Restores Vpx
Expression and HIV-2 Replication in a
Primary Trophoblast Cell Line
Previous studies showed that the frequency of mother-to-
infant HIV-2 transmission is very low (<2.5%) even in the
absence of antiretroviral therapy during pregnancy (Padua
et al., 2009; Burgard et al., 2010). Although the placenta
acts as an effective barrier against HIV infection, according
to the literature, the underlying molecular mechanisms have
not been well characterized. We hypothesized that H11 is
functionally involved in the defense against HIV infection
at the placenta. To test this idea, we used siRNA targeting
H11 to inhibit endogenous H11 expression in HVT cells. In
transduced HVTs, exogenous expression of FLAG-Vpx was
relatively low, but increased dramatically following H11 siRNA
transfection (Figure 6E). Moreover the level of endogenous
SAMHD1 was reduced in concert with an increase of Vpx
expression (Figure 6E). To further explore the relevance of
this phenomena, we asked whether knockdown of H11 would
affect HIV-2 replication. As a replication marker, we measured
luciferase activity in cells infected with HIV-2 reporter virus. The
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FIGURE 5 | H11 expression decreases single-round HIV-2 infection in MDMs. (A) Schematic representation of the experimental system. (B, C) HEK 293T
cells were co-transfected with pHIV-21env-luc or pHIV-21env1Vpx–luc and with pVSV-G. Viral release was measured by quantitation of p27 antigen concentration
in culture supernatants at 48 h post-transfection. THP-1 cells were differentiated with PMA for 24 h, and then transfected with plasmids encoding HA-H11 or empty
vector (negative control). Twenty-four hours post-transfection, cells were infected with VSV- pseudotyped WT or 1Vpx viruses for 48 h. (B) Viral infectivity was
detected by measuring luciferase activity in cell lysates. Data are means ± S.E.M. of three independent experiments. ∗∗p < 0.05, Student t-test. (C) Forty-eight hours
after infection, cells were harvested and analyzed by western blotting using the indicated antibodies. Represent results from one of three independent experiments.
Bar charts indicate amounts of SAMHD1, as determined by densitometric analysis of western blots. Data are means ± S.E.M. of three independent experiments.
luciferase activity of HIV-2 Luc was elevated in H11-suppressed
HVT cells, whereas that of the Vpx-null (HIV-21Vpx) virus
was not significantly affected (Figure 6F). These results further
support the idea that HIV-2 replication in human trophoblast
cells is negatively regulated by H11-mediated degradation and
functional disruption of Vpx.
DISCUSSION
Identification of new virus–host cell interactions is a key
challenge in clarifying the nature of viral infection and
pathogenesis. An understanding of the molecular mechanisms
underlying the virus–host interaction will facilitate the
development of new therapeutic strategies against viral infect-
ions. Thus, establishment of assay system for comprehensive
analysis of virus–host protein interaction may lead to new
advances in virus research.
In this study, we developed a new assay system that combines
wheat germ CFPS and the AlphaScreen system. This method
enabled us to comprehensively screen for any kind of robust
virus–host protein interaction. As an illustration, we utilized our
system to identify a host factor that interacts with HIV-2 Vpx.
We found that H11 interacts with HIV-2 Vpx and promotes its
degradation via a proteasome-dependent pathway. In addition,
we demonstrated that H11 is highly expressed in human
trophoblasts and may prevent maternal-to-fetal transmission
of HIV-2 during pregnancy. Thus, our proteomic approach
is an efficient and powerful tool for revealing biologically or
pathologically relevant molecular events in virus infection.
We exploited the AlphaScreen system to systematically
measure virus–host protein interactions. One major advantage
of the AlphaScreen technology is that it is a homogeneous
(no-wash) assay and can be applied to crude samples such
as tissue homogenates, cell lysates, cell culture supernatants,
and cell extracts. AlphaScreen beads can only recognize the
objective proteins with a specific epitope tag, permitting us to
use non-purified proteins synthesized in a wheat cell-free system.
This advantage saves considerable time and labor on protein
extraction and purification.
For reliable and efficient screening of protein–protein
interactions, it is necessary to use proteins with proper
tertiary structures and biological functions. Wheat germ CFPS
is a eukaryotic translation system that synthesizes proteins
that are properly folded and biologically active, as in living
mammalian cells. Another desirable property of wheat germ
CFPS is its suitability for viral protein production. Viral
proteins are usually insoluble and form aggregates in inclusion
bodies in living cells. Moreover, viral proteins are generally
cytotoxic and induce cell death upon expression. The wheat
germ cell-free system is able to produce proteins that are
relatively insoluble in other systems because it can tolerate
alterations in buffer components, including adjustments to salt
concentration and/or addition of various detergents. These
advantages underscore the suitability and availability of the
wheat germ CFPS for the generation of viral proteins that
can be used for comprehensive protein–protein interaction
assays.
We introduced the wheat germ CFPS to provide a set of
recombinant proteins from a cDNA library of human protein
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FIGURE 6 | H11 regulates HIV-2 infection in primary trophoblast cells. (A) H11 mRNA levels in human organs and tissues. FPKM values for human H11 were
obtained from the Human Protein Atlas Database (www.proteinatlas.org). (B) H11 protein expression in six cell lines (HEK293, THP-1 THP-1–derived macrophage,
MonoMac 6, and HVT) were examined by western blot; vinculin was used as an internal control. (C) Immunoprecipitation of HIV-2 Vpx with H11 in HVT cells. HVT
cells were transfected with FLAG-tagged HIV-2 Vpx, and cells were treated with 20 µM of MG132 from 6 h before harvest. Cells were harvested at 24 h after
transfection, and lysates were immunoprecipitated with anti-FLAG. Input and immunoprecipitation samples were then probed with anti-H11 and anti-FLAG
antibodies. (D) Immunohistochemistry (IHC) for detection of H11 in fourth week of human placental tissue. Brown color, IHC staining; blue color, hematoxylin
counterstain. PV, placental villi; CTB, cytotrophoblast; STB, syncytiotrophoblast. Scale bars, 100 µm. (E) HVT cells were transfected with control or H11-targeted
siRNA for 24 h, and then transfected with FLAG-Vpx. Twenty-four hours after transfection, cells were harvested and analyzed by western blotting using the indicated
antibodies. Represent results from one of three independent experiments. Bar charts indicate the amounts of Vpx or SAMHD1, as determined by densitometric
analysis of western blots. Data are means ± S.E.M. of three independent experiments. (F) HVT cells were transfected with control or H11-targeted siRNA for 24 h
before infection with HIV-2. Twenty-four hours after infection, cells were harvested. Viral infectivity was detected by measuring luciferase activity in cell lysates. Data
are means ± S.E.M. of three independent experiments. ∗∗∗p < 0.01, Student’s t-test. Left panel shows schematic representation of the experimental system.
(G) Proposed model for H11-mediated regulation of HIV-2 in trophoblast cells. In the absence of H11, Vpx proteins are delivered into target cells by HIV-2 infection
and degrade the host restriction factor SAMHD1, leading to productive infection. On the other hand, when H11 is present, it directly interacts with Vpx, leading to its
degradation; consequently, SAMHD1 is liberated from Vpx and able to inhibit HIV-2 replication.
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kinases. Our system can produce proteins from linear cDNA
templates generated by PCR (Sawasaki et al., 2007; Matsuoka
et al., 2010; Matsunaga et al., 2015). Moreover, when a biotin
ligation sequence is inserted into cDNAs by PCR, biotinylated
proteins can be readily synthesized in the presence of biotin and
biotin ligase. The biotinylated proteins are readily discernible
by streptavidin, which has high affinity for biotin, and clearly
recognized in a homogenous condition such as AlphaScreen
assay system (Sawasaki et al., 2008; Matsuoka et al., 2010). Based
on these features and the aforementioned advantages, we can
perform high-throughput assays under optimal experimental
conditions using selective cDNA libraries, e.g., the human protein
kinase library used in this study.
HIV-2 infection occurs mainly in West Africa, but its
prevalence is increasing in Europe, India, and the United States.
Compared with HIV-1, HIV-2 exhibits a longer asymptomatic
phase, slower progression to terminal immunosuppression, and
lower efficiency of both transmission and replication (∼30-fold
lower than HIV-1; Popper et al., 1999; MacNeil et al., 2007;
Gottlieb et al., 2008; Gueudin et al., 2008; Nyamweya et al.,
2013; Menendez-Arias and Alvarez, 2014). These observations
suggest the existence of different modes of host–virus interaction
in HIV-2 infection. HIV-2 encodes an accessory protein, Vpx,
degrades the cellular restriction factor SAMHD1, which strongly
inhibit viral replication in non-dividing cells (Berger et al.,
2011; Hrecka et al., 2011; Laguette et al., 2011). Moreover,
Vpx enhances nuclear import of the pre-integration complex
following infection (Shingai et al., 2015). Vpx is thus essential
to maintenance of productive HIV-2 infection in non-dividing
cells. However, it remains unclear how Vpx function is regulated
in terms of virus–host interaction. Therefore, we focused on Vpx
as a target of our proteomic analysis to elucidate host molecular
mechanisms involved in the functions and regulation of Vpx in
HIV-infected cells.
Viruses can pass through the placental barrier from maternal
to fetal blood. A pregnant woman infected with HIV can
transmit the virus to her fetus at any time during pregnancy.
Previous reports showed that trophoblastic cells of human
placenta tissue express CD4 and/or chemokine receptors, such
as CCR-5 and CXCR-4, and susceptible to HIV infection
(Amirhessami-Aghili and Spector, 1991; Ishii et al., 2000), and
both HIV-1 and -2 have been detected in situ in placental
syncytiotrophoblasts of HIV-positive pregnant women (Lewis
et al., 1990; Backe et al., 1992). However, placental HIV-1
and -2 infection during the neonatal period seems to be rare,
although the risk of infection becomes much higher during
labor and vaginal delivery (Leroy et al., 2002; Padua et al.,
2009; Burgard et al., 2010). These results suggest the presence
of novel restriction factor(s) in trophoblasts that are capable
of suppressing maternal-to-fetal transmission of HIV. In this
study, we identified H11 as a putative restriction factor that
may suppress HIV-2 replication in THP-1 and trophoblastic
cells (Figure 6G). Our proteomic analysis revealed that H11 can
bind directly to Vpx and promote its proteasomal degradation.
Consequently, the host restriction factor SAMHD1 is liberated
from Vpx and can suppress HIV-2 replication. H11 is not
expressed in immune cells such as MDMs and T cells, but is
highly expressed in human placental trophoblastic cells, to a
greater extent in the outer syncytiotrophoblast rather than in
the inner cytotrophoblast. Previous reports suggested that the
antiviral activity of SAMHD1 is limited to non-dividing cells such
as terminally differentiated myeloid cells and quiescent CD4+
T lymphocytes. Because syncytiotrophoblasts are generally fully
differentiated and non-dividing cells, H11 may give these cells the
ability to suppress HIV-2 transmission. Further careful analysis
with human samples is necessary to delineate the biological
function of H11 in HIV infection.
In summary, we developed a novel protein–protein
interaction assay system that combines the wheat germ CFPS
system with AlphaScreen technology. Our assay system provides
rapid and reliable experimental format for uncovering novel
virus–host protein interactions. Further evaluation using
different viral species and different sets of human cDNA libraries
could validate the utility and benefit of this system for future
virological research.
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